Medplus Health Services Share Price
Small Cap | Pharmaceuticals and health care | NSE: MEDPLUS | BSE: 543427
₹708.40 3.45 (0.49 %)
Last Updated: 13 Mar 2025 12:00 AM
Overview
Open (₹) 700.70
High (₹) 711.80
Low (₹) 697.65
Prev. Close (₹) 704.95
Volume 2,612
VWAP (₹) 716.79
ROCE (%) 6.85
Industry P/E 43.95
TTM P/E 64.05
P/B Ratio 5.37
Market Cap (₹) Cr.8,487.49
Dividend Yield (%)--
EPS (₹) 5.45
ROE4.13%
Sales Growth (%) 23.42
Profit Growth (%)30.88
Day Range
711.80711.80
52 Week Range
615.55876.75
Historical Returns
Returns (6M)
2.66 %
Returns (1Y)
5.98 %
Returns (3Y)
-29.09 %
Returns (5Y)
-36.8 %
Returns (6M)
2.66 %
Returns (1Y)
5.98 %
Returns (3Y)
-29.09 %
Returns (5Y)
-36.8 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (30.70%) TTM EPS Growth
- Company with no debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 30.70% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
RSI 31.81
MFI 15.40
ATR 29.03
Commodity Channel Index -99.96
ROC125 6.65
ROC21 -1.94
Williams %R -86.48
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 727.34 | 738.17 | 747.34 | 718.17 | 707.34 | 698.17 | 687.34 |
Week Ago | 754.60 | 786.35 | 803.65 | 737.30 | 705.55 | 688.25 | 656.50 |
Month Ago | 726.14 | 742.82 | 753.89 | 715.07 | 698.39 | 687.32 | 670.64 |
EMA & SMA
708.40
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 721.42
9 Day 728.66
10 Day 727.19
12 Day 736.79
14 Day 740.54
20 Day 754.12
26 Day 741.95
50 Day 782.48
100 Day 750.29
200 Day 717.37
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
03 Jan, 2025 | Lone Furrow Investment Private Limited | Pledge | ₹831.75 | 5,00,000 | BSE |
03 Jan, 2025 | MADHUKAR REDDY GANGADI | Pledge | ₹847.20 | 19,17,987 | BSE |
30 Dec, 2024 | Lone Furrow Investment Private Limited | Revoke | ₹839.15 | 1,53,55,562 | BSE |
24 Dec, 2024 | MADHUKAR REDDY GANGADI | Pledge | ₹865.75 | 1,34,32,413 | BSE |
23 Aug, 2024 | MADHUKAR REDDY GANGADI | Revoke | ₹639.25 | 68,72,565 | BSE |
23 Aug, 2024 | AGILEMED INVESTMENTS PRIVATE LIMITED | Pledge | ₹639.25 | 68,72,565 | BSE |
17 Feb, 2024 | AGILEMED INVESTMENTS PRIVATE LIMITED | Pledge | ₹602.95 | 3,62,079 | BSE |
17 Feb, 2024 | Lone Furrow Investments Private Limited | Pledge | ₹679.70 | 5,32,732 | BSE |
15 Feb, 2024 | AGILEMED INVESTMENTS PRIVATE LIMITED | Pledge | ₹627.30 | 2,17,600 | BSE |
15 Feb, 2024 | Lone Furrow Investments Private Limited | Pledge | ₹640.70 | 14,00,000 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
13 Mar, 2025 | NSE India | Medplus Health Services Limited has informed the Exchange regarding Change in Director(s) of the company. |
13 Mar, 2025 | NSE India | Medplus Health Services Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot |
13 Mar, 2025 | NSE India | Medplus Health Services Limited has informed the Exchange regarding Proceedings of Postal Ballot |
13 Mar, 2025 | BSE India | Intimation as Regulation 30 for declaration of results of Postal Ballot of the Company and details of E- voting as per Regulation 44(3) of the Listing Regulations, 2015 |
13 Mar, 2025 | BSE India | Submission of Outcome of Postal Ballot- Scrutiniser''s Report |
13 Mar, 2025 | BSE India | Declaration of results of the Postal Ballot of the Company and details of the voting as per Regulation 44(3) of the Listing Regulations, 2015 |
13 Mar, 2025 | NSE India | Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
13 Mar, 2025 | BSE India | Update under Regulation 30 read with Para A Part A of Schedule III of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 |
12 Mar, 2025 | NSE India | Intimation under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
11 Mar, 2025 | NSE India | Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 11 Oct, 2024 | 12 Nov, 2024 |
Quarterly Results | -- | 01 Jul, 2024 | 02 Aug, 2024 |
Audited Results | -- | 02 Apr, 2024 | 28 May, 2024 |
Others | Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. | 19 Feb, 2024 | 21 Feb, 2024 |
Quarterly Results | -- | 28 Dec, 2023 | 02 Feb, 2024 |
Quarterly Results | (Revised) | 27 Oct, 2023 | 08 Nov, 2023 |
Quarterly Results | -- | 27 Oct, 2023 | 26 Oct, 2023 |
Others | -- | 10 Oct, 2023 | 11 Oct, 2023 |
Others | -- | 04 Oct, 2023 | 05 Oct, 2023 |
Quarterly Results | (Revised) | 12 Jul, 2023 | 07 Aug, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Medplus Health Services
Medplus Health Services is a Public Limited Listed company incorporated on 30/11/2006 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85110TG2006PLC051845 and registration number is 051845. Currently Company is involved in the business activities of Retail sale of pharmaceuticals, medical and orthopaedic goods and toilet articles. Company’s Total Operating Revenue is Rs. 467.03 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2006
Managing Director
-- --
NSE Symbol
MEDPLUS
Medplus Health Services Management
Name | Designation |
---|---|
Mr. Gangadi Madhukar Reddy | Chairman & M.D & CEO |
Dr. Cherukupalli Bhaskar Reddy | Whole Time Director & COO |
Mr. Anish Kumar Saraf | Non Executive Director |
Mr. Madhavan Ganesan | Ind. Non-Executive Director |
Mr. Murali Sivaraman | Ind. Non-Executive Director |
Ms. Aparna Surabhi | Addnl.Non Exe.Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45 ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45 ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Medplus Health Services
What is the share price of Medplus Health Services?
The share price of Medplus Health Services on 13 Mar, 2025 is ₹ 708.40.
What is 52W high and 52W low share price of Medplus Health Services?
The highest and lowest 52W share prices of Medplus Health Services are ₹ 876.750 and ₹ 615.550
What is the market cap of Medplus Health Services?
The market capitalization of Medplus Health Services as of 13 Mar, 2025 is ₹ 8,487.49 Crores
What is the P/E ratio of Medplus Health Services?
The current P/E ratio of Medplus Health Services as of 13 Mar, 2025 is 43.95
What is the PB ratio of Medplus Health Services?
The PB ratio of Medplus Health Services as of 13 Mar, 2025 is 5.37
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)